Skip to main content

Table 1 Sleep in SARS vs. Healthy Controls

From: Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study

Sleep Parameter

SARS

Healthy Controls

Significance

 

Mean (SD)

Mean(SD)

P

Sleep onset latency ( min.)

24.13 (21.63)

29.34(31.48)

n.s.

Total sleep time (min)

370.83 (83.84)

343.43(38.47)

n.s.

Sleep Efficiency %

77.44 (13.56)

83.23( 12.36)

n,s.

Stage 1%

9.11 (4.13)

6.60(4.61)

n.s.

Stage 2%

60.22 (9.95)

49.77(6.53)

p = 0.006

Stage 3%

7.83 (6.36)

4.84(2.11)

n.s.

Stage 4%

6.27 (5.80)

9.70 (2.84)

p = 0.051.

REM onset Latency ( min.)

136.79 (63.72)

87.23 (38.47)

p = 0.004

REM %

16.57 (5.94)

17.27 (5.35)

n.s.

Apnea/Apnea-Hypopneas Index (no. per hr.of sleep)

4.70 (5.53)

2.73 (2.08)

n.s.

REM Apnea-Hypopnea Index (no. per hr.of REM sleep)

14.33 (15.41)

N/A

N/A

NREM 02 saturation (max/min)

99.13 (0.68) 92.09 (3.61)

N/A

N/A

REM 02 saturation (max/min)

98.69 (0.93)/92.24 (4.60)

N/A 96.50 (0.71)

N/A N/A